In a pandemic the pharmaceutical industry is hailed as a saviour; yet the industry is using the crisis to lock in its problematic, profit-maximising model. Pushing for public money with no-strings-attached, and stronger monopoly patent rules, the industry’s wish-list could restrict access to COVID-19 drugs and vaccines, prolonging the pandemic in the name of profit. Control over prices and access must not be left in private hands: health is a human right.
Related Articles

Economics
Bill Mitchell: Two diametrically-opposed approaches to dealing with inflation – stupidity versus the Japanese way
Bill analyses Japan’s inflation policy in coparison to those of Western nations. Read Here Bank of Japan Wikimedia Commons

EU politics
Vila Web: Immunity of Catalan pro-independence MEPs provisionally restored
Court of Justice of the European Union (CJEU) grants status to Puigdemont, Comín and Ponsatí Read Here

Finance
Reuters – Corona Crisis: California sues Uber, Lyft over misclassifying drivers as contractors
California and three of its largest cities on Tuesday sued Uber Technologies Inc and Lyft Inc, accusing them of classifying their drivers improperly as independent contractors instead of employees, evading workplace protections and withholding worker […]
Be the first to comment